PharmTech Drug Digest 11.20
News|Articles|January 2, 2020

Editorial Educational Picks for Pharmapack 2020

A selection of interesting conferences, technical presentations, and Learning Lab presentations as chosen by the editorial team of Pharmaceutical Technology Europe.

Listed below is a selection of interesting conferences, technical presentations, and Learning Lab presentations as chosen by the editorial team of Pharmaceutical Technology Europe:

Wednesday 5 February

Conference

  • 10:55–11:20: Enabling Smart Packaging for Pharma Through Printable and Flexible Hybrid Electronics-How Can We Make Our Packaging Truly Intelligent? (Alex Cole, CPI)

  • 11:45–12:15: Risks and Real-World Issue with Connected Devices (Tom Oakley, Springboard)

  • 14:00–14:20: HPRC (Healthcare Plastics Recycling Council): A Collaborative, Value Chain Approach to Enabling Plastic Recycling (Juha-Pekka Pöyry, DuPont)

  • 15:30–15:55: Implementing Circular Product Design on the Journey Towards Zero Environmental Impact (Nanja Hedal Kløverpris, Novo Nordisk)

  • 16:45–17:10: Preparing for the Black Swan: A Playbook for Exiting PVC in Pharmaceutical Flexible Packaging (Peter J. Schmitt, Montesino Associates)

Workshops

  • 09:10–09:50: Impact of Medical Device Regulation on Drug/Device Combinations-Are the Market Players Ready? (Dr. Michael Gschwandtner, Anteris medical)

  • 16:30–17:10: Feasibility of Large Volume Drug Delivery in Subcutaneous Injections (Natasha Bolick, Becton Dickinson Technologies and Innovation)

Learning Lab

  • 10:10–10:40: Changing Regulatory Requirements for Extractables & Leachables Testing on Pharmaceutical Packaging Systems (Dr. Anja Cerstiaens, Nelson Labs Europe)

  • 15:10–15:40: Inhaler Devices and the Environment: Going Green Needn’t Cost the Earth (Chris Baron, Aptar Pharma)

Thursday 6 February

Conference

  • 09:00–09:15: Global Outlook for Biologics and Biosimilars (AurelioAras, IQVIA)

  • 09:15–09:40: How Formulation Triggers Device Development (Christian Dechant, Boehringer Ingelheim)

  • 10:20–10:45: Understanding the Complexities of Delivering a Biologic Drug to the Market (Fran L. DeGrazio, West Pharmaceutical Services)

  • 14:05–14:30: Change as a Prerequisite to Enhancing Innovation Capabilities for Organizations (Marc Rohrschneider, Novartis)

  • 14:30–14:55: Using Blockchain Across the Pharmaceutical Supply Chain (Jason Lacombe, Veratrak)

Workshops

  • 10:00–10:40: New Therapy Request on New Container Solutions (Dr. Wenzel Novak, Gerresheimer, and Dr. Paul Senn, Sensile Medical)

Pharmapack Awards

  • 15:20–16:30: Pharmapack Awards 2020 Winners’ Presentation

Learning Lab

  • 12:50–13:20: Digitization of the Packaging Supply Chain (Dr. Daniel Keesman, August Faller)

  • 14:30–15:00: Protecting Health vs. Sustainable Packaging-Dream or Reality? (Peik-Christian Witte, Sanner)

 


Related to this article

Are Your Supplier Selection and Oversight Processes Robust Enough?
Despite best efforts to ensure a contract organization is following GMPs, a warning letter is issued by the FDA. Susan J. Schniepp, distinguished fellow at Nelson Labs, and Siegfried Schmitt, PhD, vice president, Technical at Parexel, provide advice for create a robust supplier selection and oversight system.
white pill capsule isolated on white background | Image Credit: ©F16-ISO100 -stock.adobe.com
PharmTech spoke with Chiara Bergerone, deputy CEO of Roquette’s Health & Pharma Solutions Business, about the company’s hydroxypropyl methylcellulose (HPMC) capsule, which was previewed at CPHI Milan 2026 in October.
Transitioning mRNA from R&D to GMP
Marco Pupo, PhD, innovation and development coordinator at Anemocyte, discusses the R&D-to-GMP transition and the changing shape of mRNA manufacturing facilities.